BIOMERIEUX

• BIOMERIEUX $1,480,000 In-house, the client's own filings · 7 filings
• ALSTON & BIRD LLP $380,000 Outside firm · 7 filings
• BALLARD PARTNERS $120,000 Outside firm · 3 filings
• BGR GOVERNMENT AFFAIRS $60,000 Outside firm · 2 filings
• GROUNDSWELL STRATEGY LLC $35,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 5269
  RESULTS Act
  5 filings
• S. 2761
  RESULTS Act
  5 filings
• H.R. 1
  One Big Beautiful Bill Act
  2 filings
• H.R. 3164
  Ensuring Community Access to Pharmacist Services Act
  2 filings
• S. 2426
  Equitable Community Access to Pharmacist Services Act
  2 filings

• 2026 $740,000 9 filings
• 2025 $1,335,000 17 filings

• Health Issues 15
• Budget/Appropriations 11
• Medical/Disease Research/Clinical Labs 11
• Medicare/Medicaid 7
• Tariff (miscellaneous tariff bills) 7
• Trade (domestic/foreign) 7
• Food Industry (safety, labeling, etc.) 3
• Taxation/Internal Revenue Code 3
• Pharmacy 2
• Manufacturing 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 15
• SENATE 15
• Centers For Medicare and Medicaid Services (CMS) 4
• Agriculture, Dept of (USDA) 3
• Health & Human Services, Dept of (HHS) 3
• Veterans Affairs, Dept of (VA) 3
• Office of Management & Budget (OMB) 1

• BIOMERIEUX, S.A. France named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.